Cargando…
Human monoclonal antibodies as candidate therapeutics against emerging viruses
The emergence of new pathogens, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and Ebola virus, poses serious challenges to global public health and highlights the urgent need for novel antiviral approaches. Monoclonal antib...
Autores principales: | Jin, Yujia, Lei, Cheng, Hu, Dan, Dimitrov, Dimiter S., Ying, Tianlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088856/ https://www.ncbi.nlm.nih.gov/pubmed/29159596 http://dx.doi.org/10.1007/s11684-017-0596-6 |
Ejemplares similares
-
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
por: Zhu, Zhongyu, et al.
Publicado: (2013) -
Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008) -
Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015) -
A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019) -
Antibody-based therapeutics against components of the IGF system
por: Feng, Yang, et al.
Publicado: (2012)